Flu Clinical Trial - Alere i FluA*B Biologic Test Relocated in Emergency

Clinical Trial Summary

It appears that the heavyness of flu pathology, the diagnosis limits and the validity of it was well studied in the last years.However, the economical impact and the organisation benefit in emergency service is not yet evaluated Our purpose is to study the impact of implementation of fast flu diagnosis by molecular biology available in emergency service in the economic field .

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT06057727` - Behavioral Economics to Improve Flu Vaccination Using EHR Nudges	N/A
Completed	`NCT03694808` - FLUAD vs. FLUZONE HD Influenza Vaccine in Residents of Long Term Care	Phase 4
Completed	`NCT06385821` - A Study to Prove Non-inferior Immunogenicity of Grippol Quadrivalent Compared to Grippol Plus	Phase 3
Completed	`NCT01440205` - Licensing Flu Shot Study	N/A
Terminated	`NCT00769002` - PET-CT Scans in Healthy Volunteers After Flu Vaccination	N/A
Completed	`NCT03308825` - Safety and Immunogenicity of Fluzone® Quadrivalent and Fluzone® High-Dose, Influenza Vaccines	Phase 4
Completed	`NCT03189537` - Study of Post-Exposure Ingavirin® Prophylaxis of Influenza and Acute Respiratory Viral Infections	Phase 3
Completed	`NCT01484522` - Laboratory Study of Licensed H1N1 Influenza Vaccines in HIV-1 Perinatally Infected Children and Youth	N/A
Completed	`NCT03344029` - Immunogenicity and Safety of the Shenzhen Trivalent Inactivated Influenza Vaccine Versus a Trivalent Influenza Vaccine Comparator in Chinese Subjects 18 to 59 Years	Phase 4
Completed	`NCT01459952` - A Double-blind, Randomised, Parallel Group,Comparative Study With Rose-hip Liquid and Placebo Given to Healthy Volunteers in the Winter Season Aiming to Evaluate the Occurences of Flu and Catching a Cold	Phase 3
Completed	`NCT00644540` - Immunogenicity and Safety Following a Single Dose of Influenza Vaccines in Healthy Children Who Received Either One or the Other Vaccine (an Adjuvanted Sub-unit Influenza Vaccine and a Non-adjuvanted Split Virion Influenza Vaccine) in the Previous V70P2 Study	Phase 2
Recruiting	`NCT06158659` - Improved Immunology Outcomes Associated With Lactoferrin Fortified With HMO in Infant Formula	N/A
Completed	`NCT05417997` - Effect of Kunamin in SARS-CoV-2 RT-PCR Positive Covid-19 Patients	Phase 3
Completed	`NCT01389518` - Efficacy and Safety of Paracetamol, Chlorpheniramine and Phenylephrine in the Treatment of Common Cold and Flu Syndrome	Phase 3
Completed	`NCT02822105` - Safety and Immunogenicity Study of H3N2 M2SR Monovalent Influenza Vaccine in Healthy Volunteers	Phase 1
Withdrawn	`NCT02037282` - A Phase 1, Open Label, Ascending Dose Cohort Study of the Pharmacokinetics of Anti-Influenza Hyperimmune Intravenous Immunoglobulin in Healthy Subjects	Phase 1
Completed	`NCT04153331` - Burden of Influenza at Emergency Department Level : BIED	N/A
Not yet recruiting	`NCT05473325` - Benchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY)
Completed	`NCT01533220` - Efficacy of Nasal Naphazoline Hydrocloride + Pheniramine Maleate + Panthenol Compared With Naphazoline Hydrocloride in the Symptomatic Control of Nasal Congestion and Nasopharyngeal	Phase 3
Recruiting	`NCT04515446` - Quantification of Viral Load in the Upper Respiratory Tract in Patients Treated With Olsetamivir for Influenza	N/A

NCT number	NCT03293979
Study type	Observational
Source	Groupe Hospitalier Paris Saint Joseph
Contact
Status	Completed
Phase
Start date	January 22, 2016
Completion date	June 30, 2018

Alere i FluA*B Biologic Test Relocated in Emergency Service for Flu Diagnosis

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms